HISTOGEN INCHH

HISTOGEN INC

0.0300USDD
0.00000.00%
As of today at 17:50 GMT
USD
No trades
See on Supercharts

HSTOQ fundamentals

Key facts

Market capitalization‪128.15 K‬USD
Founded2005
CEOSusan A. Knudson
About

Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. It focuses on Human Multipotent Cell Conditioned Media, Human Extracellular Matrix, and Hair Stimulating Complex. The company was founded by Steven J. Mento and Gail K. Naughton on July 13, 2005 and is headquartered in San Diego, CA.

Ownership
‪‪4.27 M‬‬
Free Float shares
‪‪4.15 M‬‬ (97.24%)
Closely held shares
‪‪117.95 K‬‬ (2.76%)
Free Float shares
‪‪4.15 M‬‬ (97.24%)
Closely held shares
‪‪117.95 K‬‬ (2.76%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪128.15 K‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪30.00‬
‪60.00‬
‪90.00‬
‪120.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−77,200.00%‬
‪−76,650.00%‬
‪−76,100.00%‬
‪−75,550.00%‬
‪−75,000.00%‬
Q3 '23
‪‪−4.50 M‬‬
‪‪−3.00 M‬‬
‪‪−1.50 M‬‬
‪0.00‬
‪‪1.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
‪‪1.30 K‬‬
‪‪2.60 K‬‬
‪‪3.90 K‬‬
‪‪5.20 K‬‬
Actual
Earnings
Next:May 9, 2025
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪−1.00‬
‪−0.75‬
‪−0.50‬
‪−0.25‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

HSTOQ does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.